Showing results (1131-1140 of 1,375) with videos related to

Sort By:
Pageof 138
Biomedicines|January 23, 2024
Quantitative Computed Tomography Lung COVID Scores with Laboratory Markers: Utilization to Predict Rapid Progression and Monitor Longitudinal Changes in Patients with Coronavirus 2019 (COVID-19) PneumoniaDa Hyun Kang, Grace Hyun J Kim, Sa-Beom Park, et al.
International Journal of Hematology|August 22, 2017
Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 yearsHyunkyung Park, Jeonghwan Youk, Hak Ro Kim, et al.
Annals of Internal Medicine|February 2, 2011
Effect of routine sterile gloving on contamination rates in blood culture: a cluster randomized trialNak-Hyun Kim, Moonsuk Kim, Shinwon Lee, et al.
International Journal of Pharmaceutics|February 11, 2017
A three-dimensional assemblage of gingiva-derived mesenchymal stem cells and NO-releasing microspheres for improved differentiationShobha Regmi, Jiafu Cao, Shiva Pathak, et al.
Cell|May 13, 2014
Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulationSooyoung Chung, Eun Jeong Lee, Seongsik Yun, et al.
AIDS Research and Human Retroviruses|February 16, 2008
Prevalence of primary antiretroviral resistance: trends in KoreaJ I Hwan Bang, Kyoung Ho Song, Sung-Han Kim, et al.
Journal of Rheumatic Diseases|July 21, 2023
Association of Serum Biomarkers With Pulmonary Involvement of Rheumatoid Arthritis Interstitial Lung Disease: From KORAIL Cohort Baseline DataJinyoung Moon, Jeong Seok Lee, Young Im Yoon, et al.
Oncotarget|November 9, 2016
Therapeutic effect of erythroid differentiation regulator 1 (Erdr1) on collagen-induced arthritis in DBA/1J mouseKyung Eun Kim, Sungryung Kim, Sunyoung Park, et al.
The Oncologist|October 11, 2022
Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant TreatmentJinyong Kim, Euijin Chang, Song Yi Park, et al.
Vaccine|June 2, 2019
Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical studyChang Kyung Kang, Nak-Hyun Kim, Chung-Jong Kim, et al.
Pageof 138